X-18907981-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000292.3(PHKA2):​c.2436G>A​(p.Gly812Gly) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0099 in 1,209,092 control chromosomes in the GnomAD database, including 64 homozygotes. There are 3,825 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. G812G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.0073 ( 3 hom., 249 hem., cov: 23)
Exomes 𝑓: 0.010 ( 61 hom. 3576 hem. )

Consequence

PHKA2
NM_000292.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.11

Publications

1 publications found
Variant links:
Genes affected
PHKA2 (HGNC:8926): (phosphorylase kinase regulatory subunit alpha 2) Phosphorylase kinase is a polymer of 16 subunits, four each of alpha, beta, gamma and delta. The alpha subunit includes the skeletal muscle and hepatic isoforms, and the hepatic isoform is encoded by this gene. The beta subunit is the same in both the muscle and hepatic isoforms, and encoded by one gene. The gamma subunit also includes the skeletal muscle and hepatic isoforms, which are encoded by two different genes. The delta subunit is a calmodulin and can be encoded by three different genes. The gamma subunits contain the active site of the enzyme, whereas the alpha and beta subunits have regulatory functions controlled by phosphorylation. The delta subunit mediates the dependence of the enzyme on calcium concentration. Mutations in this gene cause glycogen storage disease type 9A, also known as X-linked liver glycogenosis. Alternatively spliced transcript variants have been reported, but the full-length nature of these variants has not been determined.[provided by RefSeq, Feb 2010]
PHKA2 Gene-Disease associations (from GenCC):
  • glycogen storage disease IXa1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics
  • glycogen storage disease due to liver phosphorylase kinase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant X-18907981-C-T is Benign according to our data. Variant chrX-18907981-C-T is described in ClinVar as Benign. ClinVar VariationId is 255773.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.11 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00731 (818/111916) while in subpopulation NFE AF = 0.0112 (595/53127). AF 95% confidence interval is 0.0105. There are 3 homozygotes in GnomAd4. There are 249 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 XL,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000292.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHKA2
NM_000292.3
MANE Select
c.2436G>Ap.Gly812Gly
synonymous
Exon 22 of 33NP_000283.1P46019
PHKA2
NM_001440805.1
c.2436G>Ap.Gly812Gly
synonymous
Exon 22 of 33NP_001427734.1
PHKA2
NM_001440800.1
c.2436G>Ap.Gly812Gly
synonymous
Exon 22 of 32NP_001427729.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PHKA2
ENST00000379942.5
TSL:1 MANE Select
c.2436G>Ap.Gly812Gly
synonymous
Exon 22 of 33ENSP00000369274.4P46019
PHKA2
ENST00000897868.1
c.2436G>Ap.Gly812Gly
synonymous
Exon 22 of 33ENSP00000567927.1
PHKA2
ENST00000954730.1
c.2421G>Ap.Gly807Gly
synonymous
Exon 22 of 33ENSP00000624789.1

Frequencies

GnomAD3 genomes
AF:
0.00732
AC:
819
AN:
111860
Hom.:
3
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.00153
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00673
Gnomad ASJ
AF:
0.000756
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00112
Gnomad FIN
AF:
0.0113
Gnomad MID
AF:
0.0598
Gnomad NFE
AF:
0.0112
Gnomad OTH
AF:
0.0119
GnomAD2 exomes
AF:
0.00775
AC:
1423
AN:
183527
AF XY:
0.00796
show subpopulations
Gnomad AFR exome
AF:
0.000760
Gnomad AMR exome
AF:
0.00769
Gnomad ASJ exome
AF:
0.000534
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0101
Gnomad NFE exome
AF:
0.0112
Gnomad OTH exome
AF:
0.0115
GnomAD4 exome
AF:
0.0102
AC:
11155
AN:
1097176
Hom.:
61
Cov.:
30
AF XY:
0.00986
AC XY:
3576
AN XY:
362536
show subpopulations
African (AFR)
AF:
0.00220
AC:
58
AN:
26375
American (AMR)
AF:
0.00761
AC:
268
AN:
35207
Ashkenazi Jewish (ASJ)
AF:
0.00134
AC:
26
AN:
19382
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30202
South Asian (SAS)
AF:
0.00292
AC:
158
AN:
54117
European-Finnish (FIN)
AF:
0.00950
AC:
385
AN:
40533
Middle Eastern (MID)
AF:
0.0305
AC:
126
AN:
4128
European-Non Finnish (NFE)
AF:
0.0116
AC:
9735
AN:
841175
Other (OTH)
AF:
0.00866
AC:
399
AN:
46057
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.491
Heterozygous variant carriers
0
442
883
1325
1766
2208
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
370
740
1110
1480
1850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00731
AC:
818
AN:
111916
Hom.:
3
Cov.:
23
AF XY:
0.00730
AC XY:
249
AN XY:
34088
show subpopulations
African (AFR)
AF:
0.00152
AC:
47
AN:
30822
American (AMR)
AF:
0.00673
AC:
71
AN:
10555
Ashkenazi Jewish (ASJ)
AF:
0.000756
AC:
2
AN:
2645
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3543
South Asian (SAS)
AF:
0.00112
AC:
3
AN:
2672
European-Finnish (FIN)
AF:
0.0113
AC:
69
AN:
6124
Middle Eastern (MID)
AF:
0.0607
AC:
13
AN:
214
European-Non Finnish (NFE)
AF:
0.0112
AC:
595
AN:
53127
Other (OTH)
AF:
0.0117
AC:
18
AN:
1536
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
29
58
87
116
145
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00829
Hom.:
96
Bravo
AF:
0.00681
EpiCase
AF:
0.0119
EpiControl
AF:
0.0106

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not provided (3)
-
-
2
Glycogen storage disease IXa1 (2)
-
-
2
not specified (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.71
CADD
Benign
3.3
DANN
Benign
0.48
PhyloP100
-1.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61733281; hg19: chrX-18926099; COSMIC: COSV101176883; COSMIC: COSV101176883; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.